Webdisclosure.com

Search

UCB (EBR:UCB) UCB Media Room: Disposal of own shares

Directive transparence : information réglementée

13/01/2020 20:05
https://mb.cision.com/Public/18595/3007977/b8aae7050fa7d9c4_800x800ar.jpg ** Disposal of own shares ------------------------------------------------------------ Brussels (Belgium), 13 January 2020 =E2=80=93 20:05 (CET) =E2=80=93 regulat= ed information In application of article 8:6 of the Royal Decree executing the new Belgian= Code of Companies and Associations, UCB SA/NV announces that following exe= rcises of stock options by its employees, it has disposed of UCB shares OTC= in view of deliveries of shares to the relevant employees, within the fram= ework of the Long Term Incentive Program of the UCB Group, as follows: https://mb.cision.com/Public/18595/3007977/91039f8b421bbfa9_800x800ar.jpg =C2=A0=C2=A0 This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news Image Capture 1 Disposal of Own Shares Jan 13 2020 (https://mb.cision.com/Public/= 18595/3007977/91039f8b421bbfa9_org.jpg) GenericFile 20100113- Disposal of own shares (https://mb.cision.com/Public/18595/300797= 7/8d400e2be79e0034.pdf) GenericFile 20200113 - Ali=C3=A9nation d actions propres (https://mb.cision.com/Public/= 18595/3007977/88b8986b688b3dc1.pdf) GenericFile 20100113 - Vervreemding van eigen aandelen (https://mb.cision.com/Public/18= 595/3007977/a0ee45175a932233.pdf)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x33323x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

28/01/2020 07:01
27/01/2020 20:00
20/01/2020 20:10
20/01/2020 20:05
20/01/2020 20:01
13/01/2020 20:10
13/01/2020 20:05
10/01/2020 18:10
07/01/2020 20:01
18/12/2019 18:30